Science Explorer Interactive view Map
Nonprofit · Heidelberg · Germany

Heidelberg Institute for Stem Cell Technology and Experimental Medicine

hi-stem.deROR OpenAlex
Research works
100
▲ 4% vs 2013–17
Citations
4.6k
45.7 per fractional work
Top-10% rate
31.1%
record average 16.5%
Open access
58%
world 28%

Not ranked overall: Heidelberg Institute for Stem Cell Technology and Experimental Medicine is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.78× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.42× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 7.96× its world share, 2 worksImmunology and Micro…Neuroscience: 0.70× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.82× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.46× its world share, 0 worksChemistryComputer Science: 0.09× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMathematics: 0.32× its world share, 0 worksMathematicsMedicine: 2.52× its world share, 14 worksMedicineNursing: 0.13× its world share, 0 worksNursingDecision Sciences: 0.24× its world share, 0 worksDecision SciencesPsychology: 0.10× its world share, 0 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.0×. Every wedge is a field page.

Which keywords describe research at Heidelberg Institute for Stem Cell Technology and Experimental Medicine?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Hematopoietic Stem Cells, Prognostic Factors, Acute Myeloid Leukemia, AML, Mesenchymal Stem Cells, Gene Expression, Cancer and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Hematopoietic Stem Cells4▲ 150×3 topics
  2. Prognostic Factors3▲ 27×9 topics
  3. AML3▲ 185×1 topic
  4. Acute Myeloid Leukemia3▲ 185×1 topic
  5. Cancer2▲ 5.8×21 topics
  6. Mesenchymal Stem Cells2▲ 72×2 topics
  7. Gene Expression2▲ 12×12 topics
  8. Immunotherapy2▲ 9.4×11 topics
  9. Inflammation2▲ 2.9×16 topics
  10. Tumor Microenvironment2▲ 12×7 topics
  11. Targeted Therapy1▲ 23×4 topics
  12. Cancer Genomics1▲ 62×1 topic
  13. Genomic Instability1▲ 43×2 topics
  14. Mutational Signatures1▲ 62×1 topic
  15. Stromal Cells1▲ 58×2 topics
  16. Differentiation1▲ 69×2 topics
  17. Multipotent1▲ 116×1 topic
  18. Regeneration1▲ 21×1 topic
  19. Transcriptional Regulation1▲ 27×7 topics
  20. Cancer Stem Cells1▲ 91×1 topic
  21. Immunity1▲ 9.4×5 topics
  22. Tumor Metastasis1▲ 72×1 topic
  23. Bone Marrow Niche1▲ 154×1 topic
  24. Chemotherapy1▲ 5.3×10 topics
  25. Graft-versus-Host Disease1▲ 154×1 topic
  26. Metabolism1▲ 7.1×6 topics

Which research topics does Heidelberg Institute for Stem Cell Technology and Experimental Medicine publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Mesenchymal stem cell research and Cancer Cells and Metastasis.

Acute Myeloid Leukemia R…3Acute Myeloid Leukemia Research: 3 fractional worksCancer Genomics and Diagnostics: 1 fractional worksMesenchymal stem cell re…1Mesenchymal stem cell research: 1 fractional worksCancer Cells and Metasta…1Cancer Cells and Metastasis: 1 fractional worksHematopoietic Stem Cell …1Hematopoietic Stem Cell Transplantation: 1 fractional worksSingle-cell and spatial …1Single-cell and spatial transcriptomics: 1 fractional worksImmune cells in cancer1Immune cells in cancer: 1 fractional worksPancreatic and Hepatic Oncology Research: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksEpigenetics and DNA Methylation: 0 fractional works
HematologyCancer ResearchGeneticsOncology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Myeloid Leukemia Research Hematology 3 works
  2. 2 Cancer Genomics and Diagnostics Cancer Research 1 works
  3. 3 Mesenchymal stem cell research Genetics 1 works
  4. 4 Cancer Cells and Metastasis Oncology 1 works
  5. 5 Hematopoietic Stem Cell Transplantation Hematology 1 works
  6. 6 Single-cell and spatial transcriptomics Molecular Biology 1 works
  7. 7 Immune cells in cancer Immunology 1 works
  8. 8 Pancreatic and Hepatic Oncology Research Oncology 1 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 1 works
  10. 10 Epigenetics and DNA Methylation Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.3%not open41.7%

World: 28% of research is openly available.

with international co-authors44.9%domestic only55.1%

World: 19% is written across borders.

How has Heidelberg Institute for Stem Cell Technology and Experimental Medicine's research output changed?

Output in 2018–2022 was 4% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Heidelberg

All research institutions in Heidelberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.